Global Atopic Dermatitis Market: Description
Atopic dermatitis is the type of eczema; patients who are suffering with this disease have super sensitive skin and a less threshold for irritation.
Atopic dermatitis consists of hay fever, allergic asthma, atopic dermatitis, food allergies and anaphylaxis.
The rapid development of novel pipeline drugs is expected to accelerate the market growth in the forecast period.
Likewise, the rise in demand for new biologics and product approvals are also predictable to enhance the atopic dermatitis market growth.
Furthermore, the favourable reimbursement policies in emerging countries and high prevalence of atopic dermatitis are also projected to drive the market growth rate.
Also, the increase in awareness regarding the availability of treatments for the disease and various initiatives undertaken by governments to provide better and more affordable treatment are also expected to influence the market growth globally.
Global Atopic Dermatitis Market: Overview
The Global Atopic Dermatitis Market is valued at US $5.65 Billion in 2022 is anticipated to reach a value of US $8.60 Billion in 2030, growing at a CAGR of 5.4%.
Dermatological disorders are highly prevalent in various forms across the globe. According to the World Health Organization, more than 900 million people were affected by skin diseases.
Out of these diseases, atopic dermatitis affects more than 300 million people globally.
Around one-fifth of the victims include children. This increased incidence of this disease is expected to leverage the growth of the atopic dermatitis market in the foreseeable future.
Other factors, such as the development of novel pipeline drugs and rising demand for new biologics and product approvals, are also expected to augment atopic dermatitis drugs demand.
Corticosteroids Remain the Drug of Choice
Corticosteroids are referred as the first choice of treatment for the inflammation and pain relief. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling and redness. Around 30 corticosteroid compounds have been licensed for atopic dermatitis treatment, of which ‘hydrocortisone’ is considered as the first. In addition, increasing innovations have resulted in the advent of topical non-corticosteroids immunomodulators and target medications, for example, immunomodulators such as pimecrolimus and tacrolimus, which in turn, is likely to fuel the growth of the atopic dermatitis treatment market. Moreover, topical corticosteroids are expected to play an important role in the atopic dermatitis treatment.
Rise in awareness regarding the availability of treatments for the disease
Initiatives undertaken by governments to provide better and more affordable treatment and the presence of favorable reimbursement policies are likely to provide an upthrust to the market. Furthermore, growing acceptance of targeted therapies such as Eucrisa and Dupixent is also working in favor of the market.
High cost of therapeutics is one of the key roadblocks in the upward climb of the market. However, affordable healthcare measures are being incorporated across all major regions, impacting pricing strategies of companies as well as reimbursement scenarios.
Segmental Analysis of Global Atopic Dermatitis Market:
Based on Drug Class
• Corticosteriods
• Calcenriun Inhibitors
• PDE4 Inhibitors
• Biologic
• Others
Corticosteroids have been the mainstay for AD treatment. Being the first-line therapy, this drug class is projected to maintain sizeable share in the market through 2022. Corticosteroids accounted for about 45.0% share in the market. Calcineurin inhibitors are proven to increase the chances of nephrotoxicity and carcinogenesis. Non-specificity, toxic effects, and development of resistance to this therapeutic class are poised to stifle the growth of the segment and encourage switching to other targeted therapies.
Based on Route of Administration
• Oral
• Injectable
• Tropical
Topical products led the market and represented 70.0% of the market. Topical corticosteroids are the most widely prescribed medications for AD. They are often administered in combination with moisturizers or emollients for more effective results.
Based on Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Geographical Analysis of Global Atopic Dermatitis Market:
The Global Atopic Dermatitis Market is further segmented into five major countries- North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
The U.S. market is anticipated to register a healthy CAGR during the forecast period. Increasing incidence of atopic dermatitis, soaring treatment rate, and inflated drug prices are some of the key trends augmenting revenue generation in the country.
Increased awareness about atopic dermatitis, favourable medical reimbursement policies and well-established healthcare facilities are projected to leverage Europe’s market share.
Region Covered-
• North America (US, Canada, Mexico)
• Europe (Spain, Italy, UK, Germany, France, Russia)
• Asia-Pacific (India, China, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (UAE, Saudi Arabia, South Africa)
Key Players: Abbvie INC., Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, Teva Pharmaceutical Industries Ltd., Novaritis AG, Sanofi S.A, GlaxoSmithKline PLC.
Analysis of the impact of COVID-19 and the Russia-Ukraine War:
The readers of this section will be better informed on the effects of the pandemic, the post-pandemic, and the Russia-Ukraine War on the global market for refrigerated freight services. The factors that have changed since the poll was done include demand, consumption, transportation, consumer behavior, and supply chain management. Industry experts have also emphasized the crucial factors that will help players identify opportunities and maintain the sector as a whole in the approaching years.
The main goals of report are:
- To examine and assignment the extent of the international market for the market sector.
- To Researching the important gamers globally, their SWOT analysis, market value, and market share.
- To identify, describe, and mission market based totally on type, quit use, and geography.
- To take a look at the market advantages, challenges, dangers, and constraints in the world’s principal regions.
- To pick out key traits and variables that are advertising or inhibiting market growth.
- To decide the excessive increase segments in order to have a look at the market potentialities for stakeholders.
- To consider every submarket fastidiously in phrases of its very own boom sample and market contribution.
- To know market possessions, agreements, growth, and the introduction of new merchandise as aggressive advances.
- To strategically discover the essential gamers and completely take a look at their enlargement plans.
